Corticosteroids as Rescue Therapy for the Late Phase of Acute Respiratory Distress Syndrome

• Status: Completed
• Trial end date: 2005-09-01
• Target enrollment: 0
• Participant gender: All

Summary

The purpose of this study is to assess innovative treatment methods in patients with adult respiratory distress syndrome (ARDS) as well as those at risk of developing ARDS.

• Phase: Phase 3
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: National Heart, Lung, and Blood Institute (NHLBI)

Criteria

Inclusion Criteria:

• Diagnosed with ARDS or has risk factors for ARDS; individuals will be considered at risk if they are critically ill and have trauma, sepsis, shock, pneumonia, inhalation injury, drug overdose, pancreatitis, or hypertransfusion

• Onset of ARDS must be between 7 and 28 days prior to study entry

• Since ARDS onset, bilateral infiltrates must have persisted and participants must have required continuous mechanical ventilation